Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/04/2010WO2009007992A8 Pharmaceutical composition produced by microprecipitation
03/04/2010WO2009004629A3 A method for decreasing symptoms of alcohol consumption
03/04/2010WO2009001359A3 Compositions and methods for inhibiting expression of pro-apoptotic genes
03/04/2010US20100057047 Delivery device and method
03/04/2010US20100056982 Photodynamic therapy for the treatment of acne
03/04/2010US20100056974 Bone metabolism improving agent
03/04/2010US20100056644 Pharmaceutical compositions containing anhydrous calcipotriene
03/04/2010US20100056643 Chemically induced intracellular hyperthermia
03/04/2010US20100056641 Novel Aminoguanidines as Melanocortin Receptor Ligands
03/04/2010US20100056638 Oral and Injectable Formulations of Tetracycline Compounds
03/04/2010US20100056637 Treatment methods using triaryl methane compounds
03/04/2010US20100056636 N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
03/04/2010US20100056635 Novel protein kinase modulators and therapeutic uses thereof
03/04/2010US20100056634 Novel compositions
03/04/2010US20100056633 Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof
03/04/2010US20100056632 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
03/04/2010US20100056631 Antiallergenic composition
03/04/2010US20100056629 Retrovirus-infection inhibitor
03/04/2010US20100056627 Pharmaceutical compositions of alkyl gallates
03/04/2010US20100056626 Cosmetic product for the treatment of cicatricial tissues
03/04/2010US20100056625 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone
03/04/2010US20100056624 Animal model for perimenopause and menopause and methods of inducing ovarian failure
03/04/2010US20100056623 Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same
03/04/2010US20100056622 Methods of Using Ramelteon to Treat Patients Suffering from a Variety of Neurodegenerative Diseases
03/04/2010US20100056621 Agonists of a bitter taste receptor and uses thereof
03/04/2010US20100056619 Chroman-Derived Anti-Androgens For Treatment of Androgen-Mediated Disorders
03/04/2010US20100056618 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/04/2010US20100056617 Role of limonoid compounds as neuroprotective agents
03/04/2010US20100056616 Iejimalid analoga and uses thereof
03/04/2010US20100056615 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
03/04/2010US20100056614 C10 cyclopentyl ester substituted taxanes
03/04/2010US20100056613 Spiroquinone compound and pharmaceutical composition
03/04/2010US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules
03/04/2010US20100056611 MN/CA9 Splice Variants
03/04/2010US20100056610 HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS
03/04/2010US20100056609 Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway
03/04/2010US20100056608 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2
03/04/2010US20100056607 Compositions and their uses directed to hbxip
03/04/2010US20100056606 Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha
03/04/2010US20100056605 Oxidative degradation products of atorvastatin calcium
03/04/2010US20100056604 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type iv
03/04/2010US20100056603 Ion channel modulating compounds and uses thereof
03/04/2010US20100056602 Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors
03/04/2010US20100056601 Control agent containing N-Substituted indole derivative for acarian parasitic on animal
03/04/2010US20100056600 11beta-hsd1 active compounds
03/04/2010US20100056599 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids
03/04/2010US20100056597 Indoledione derivative
03/04/2010US20100056596 Resistance-repellent retroviral protease inhibitors
03/04/2010US20100056595 Pyrazole Derivatives as P2X7 Modulators
03/04/2010US20100056593 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056592 Prodrugs of (3,5-bis(4-fluorophenyl)tetrahydro-1h-oxazolo[3,4-c]oxazol-7a-yl)methanol and derivatives thereof
03/04/2010US20100056591 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
03/04/2010US20100056590 Polymorphic forms of deferasirox (icl670a)
03/04/2010US20100056588 Histone deacetylase inhibitors
03/04/2010US20100056587 Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, And Methods Of Use
03/04/2010US20100056586 Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
03/04/2010US20100056585 N-(2-Aminophenyl)-4-[N-(Pyridine-3-yl)-Methoxycarbonyl-Aminomethyl]-Benzamide (MS-275) Polymorph B
03/04/2010US20100056584 Novel 2-aminio-pyridine derivatives and their use as potassium channel modulators
03/04/2010US20100056583 Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation
03/04/2010US20100056582 Modulators of LXR
03/04/2010US20100056581 Substituted Piperidino Phenyloxazolidinones
03/04/2010US20100056580 Novel crystalline salt form of an antidiabetic compound
03/04/2010US20100056577 Pyrrole compounds
03/04/2010US20100056576 Kinase inhibitors and methods of their use
03/04/2010US20100056575 Anesthetic Compounds
03/04/2010US20100056574 Crystalline Forms of Sufentanil
03/04/2010US20100056573 2-alkyl-indazole compounds for the treatment of certain cns-related disorders
03/04/2010US20100056572 Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
03/04/2010US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
03/04/2010US20100056569 Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents
03/04/2010US20100056568 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
03/04/2010US20100056567 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
03/04/2010US20100056566 New substituted isoquinoline and isoquinolinone derivatives
03/04/2010US20100056565 Heterocyclic Derivatives as M3 Muscarinic Receptors
03/04/2010US20100056564 Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
03/04/2010US20100056563 Novel 1.8-naphthyridine compounds
03/04/2010US20100056562 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/04/2010US20100056561 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative
03/04/2010US20100056560 Use for treating obesity and diabetes
03/04/2010US20100056559 Propellant-free aerosol formulation for inhalation
03/04/2010US20100056558 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors
03/04/2010US20100056557 Treatment for cutaneous metastases
03/04/2010US20100056556 Isoquinolinopyrrolopyridinones active as kinase inhibitors
03/04/2010US20100056555 Method of treating ras associated cancer
03/04/2010US20100056554 Use of opioid formulations in needle-less drug delivery devices
03/04/2010US20100056553 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
03/04/2010US20100056552 Combination for use in the treatment of inflammatory disorders
03/04/2010US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds
03/04/2010US20100056550 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/04/2010US20100056549 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
03/04/2010US20100056548 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
03/04/2010US20100056547 OPHTHALMIC COMPOSITIONS COMPRISING dDC
03/04/2010US20100056546 Sulfonylurea inhibitors of atp-sensitive potassium channels
03/04/2010US20100056545 Novel phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of t-type calcium ion channel containing the same as an active ingredient
03/04/2010US20100056544 Salts with CRTH2 Antagonist Activity
03/04/2010US20100056542 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056541 Biphenyl compounds useful as muscarinic receptor antagonists
03/04/2010US20100056540 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
03/04/2010US20100056539 Trazodone and trazodone hydrochloride in purified form
03/04/2010US20100056538 Pro-drugs of A2B Adenosine Receptor Antagonists
1 ... 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 ... 7860